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Background: Endoscopic transpapillary pernasal gallbladder drainage and endoscopic gallbladder stenting (EGS)
have recently been reported to be useful in patients with acute cholecystitis for whom a percutaneous approach is
contraindicated. The aim of this study was to evaluate the efficacy of permanent EGS for management of acute
cholecystitis in elderly patients who were poor surgical candidates.
Methods: We retrospectively studied 46 elderly patients aged 65 years or older with acute cholecystitis who were
treated at Japan Labour Health and Welfare Organization Niigata Rosai Hospital. In 40 patients, acute cholecystitis
was diagnosed by transabdominal ultrasonography and computed tomography, while 6 patients were transferred
from other hospitals after primary management of acute cholecystitis. All patients underwent EGS, with a 7Fr
double pig-tail stent being inserted into the gallbladder. If EGS failed, percutaneous transhepatic gallbladder
drainage or percutaneous transhepatic gallbladder aspiration was subsequently performed. The main outcome
measure of this study was the efficacy of EGS.
Results: Permanent EGS was successful in 31 patients (77.5%) with acute cholecystitis, without any immediate
postprocedural complications such as pancreatitis, bleeding, perforation, or cholangitis. The most common
comorbidities of these patients were cerebral infarction (n=14) and dementia (n=13). In 30 of these 31 patients
(96.7%), there was no recurrence of cholecystitis and 29 patients (93.5%) remained asymptomatic until death or the
end of the study period (after 1 month to 5 years).
Conclusions: EGS can be effective for elderly patients with acute cholecystitis who are poor surgical candidates
and can provide a solution for several years.
Keywords: Endoscopic gallbladder stenting, Cholecystitis, Percutaneous transhepatic gallbladder drainage,
percutaneous transhepatic gallbladder aspiration, Endoscopic transpapillary naso-gallbladder drainage, Elderly
patientsBackground
Acute calculous cholecystitis appears to arise from ob-
struction of the cystic duct or the junction between the
gallbladder and cystic duct by a stone or edema resulting
from local mucosal erosion and inflammation caused by
a stone [1]. Early cholecystectomy is the standard therapy
for acute cholecystitis [1,2]. Although cholecystectomy is
generally safe, its mortality rate increases markedly in* Correspondence: s5083m@niirou.jp
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reproduction in any medium, provided the orhigh-risk patients with comorbidities [3,4]. In critically ill
elderly patients, the mortality rate of emergency chole-
cystectomy can be as high as 30% [3,4]. Therefore, as a
temporary measure, high-risk patients are treated by de-
compression of the gallbladder using percutaneous
transhepatic gallbladder drainage (PTGBD) or percutan-
eous transhepatic gallbladder aspiration (PTGBA) [5-8].
In addition, several authors have reported that endo-
scopic transpapillary naso-gallbladder drainage (ETGBD)
is a safe and effective procedure for acute cholecystitis
[9-12]. Endoscopic gallbladder stenting (EGS) may not
only be effective for acute cholecystitis, but could also beral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics of the patients receiving EGS
No. of patients 46






EGS = endoscopic gallbladder stenting.
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atic cholelithiasis in patients who are poor surgical candi-
dates [13-24]. However, very few studies have provided
detailed long-term follow up analysis of EGS.
Here, we report our experience with various EGS tech-
niques for the management of acute cholecystitis and
evaluate the efficacy of permanent stenting as an option
in elderly patients who are poor surgical candidates.
Methods
The study population consisted of 46 patients with acute
cholecystitis who were 65 years of age or older. They were
admitted to Japan Labour Health and Welfare Organization
Niigata Rosai Hospital between 2007 and 2012. In 40 pa-
tients, acute cholecystitis was diagnosed by transabdominal
ultrasonography (US) and computed tomography (CT) at
our hospital, while 6 patients were transferred from other
hospitals after primary management of acute cholecystitis.
After endoscopic retrograde cholangiography (ERC), EGS
was attempted in all 46 patients.
ERC was performed with a video duodenoscope (JF-
260V; Olympus Medical Systems, Tokyo, Japan). Cannula-
tion of the bile duct and cystic duct was done with an over-
the-wire endoscopic retrograde cholangiopancreatography
(ERCP) cannula (Tandem XL; Boston Scientific, Tokyo,
Japan) and an 0.018, 0.025, or 0.035 inch guidewire
(Radifocus; Terumo Tokyo, Japan or Chiarida; Century
Medical Ink, Tokyo, Japan). The guidewire was advanced
retrogradely through the cannula and coiled within the
gallbladder. Over this wire, a 7Fr double pig-tail stent
(10 or 15 cm, Olympus) was advanced into the gall-
bladder (Additional file 1).
Clinical success with EGS was defined as complete
resolution of symptoms, improvement of laboratory data
(white blood cell count and C-reactive protein), and im-
provement of US findings. Follow-up of permanent EGS
patients was performed until death or the end of the
study period, with review of symptoms and laboratory
data every 3 months plus US every 6 months.
Written informed consent was obtained from the pa-
tients (or from a family member if the patient had cere-
bral infarction or dementia) and the ethics committee of
Japan Labour Health and Welfare Organization Niigata
Rosai Hospital approved this study. We obtained con-
sent for publication of all material in this article, includ-
ing the individual information contained in the tables.
Results
The characteristics of the 46 subjects are depicted in
Table 1. Their average age was 79.70±7.96 years (mean ±
standard deviation [SD]). Twenty-four patients also had
choledocholithiasis, and we performed endoscopic
sphincterotomy (EST) in 34 patients, including 10 with-
out choledocholithiasis to obtain adequate post-EGSflow in the common bile duct. Emergency EGS was suc-
cessful in 31 out of 40 patients (77.5%) with acute chole-
cystitis. We also performed elective EGS for the purpose
of permanent placement in 6 patients. We inserted a 10
cm double pig-tail stent in 7 patients and a 15 cm
double pigtail stent in 30 patients. There were no imme-
diate postprocedural complications, such as pancreatitis,
bleeding, perforation, or cholangitis.
We performed emergency EGS in 40 patients who
presented with acute severe cholecystitis and were poor
candidates for cholecystectomy. In 31 patients (77.5%),
emergency EGS was successful and the procedural time
was 27.6 ± 15.1 min (mean ± SD). Clinical success was
achieved within 3 days in all 31 patients. Their symptoms
(abdominal pain, fever, and vomiting) resolved and they
started to eat from the day after emergency EGS, and
all 31 showed normalization of WBC and a decrease of
C-reactive protein after 3 days. All were discharged from
hospital within 1 week. We administered antibiotics to all
31patients for 3 days after emergency EGS, but they did
not need ICU support, intubation, or inotropes. Among
the 31 successful patients, we used a microcatheter for
EGS in 4 difficult cases. The reasons for difficulty were se-
vere stricture and kinking of the cystic duct and we ac-
complished EGS in these cases by using an 0.018 inch
guidewire and a microcatheter (Additional file 2). The
microcatheter had an inner diameter of 0.59 mm, outer
diameter of 0.89 mm, and an effective length of 2,600 mm
(Figure 1). Of the 31 patients, 6 patients underwent chole-
cystectomy within 2 months of EGS, while 25 patients
were followed up without surgery due to their poor gen-
eral condition (Figure 2).
Among the 40 patients in whom emergency EGS
was attempted, it failed in 9 patients because the cystic
duct branched caudally from the common bile duct
(n=3), because there was severe kinking of the cystic
duct (n=3), because the cystic duct was completely
blocked by stones (n=2), or because of cystic duct adhe-
sions (n=1). Among the 9 patients in whom EGS failed,
we performed PTGBD in 6 patients and repeated
PTGBA in 3 patients. Of the 6 patients receiving
PTGBD, 5 underwent cholecystectomy within 2 months,
while 1 patient died of aspiration pneumonia after 1
Figure 1 The structure of the microcatheter used for endoscopic gallbladder stenting.
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discharged from hospital after 2 or 3 weeks.
We also performed elective EGS for the purpose of per-
manent placement in 6 patients (5 after PTGBD and 1
after conservative treatment) who were transferred from
other hospitals within 1 week after the onset of acute
cholecystitis, and the procedurewas successful in all 6
patients. In 5 patients, EGS was done by passing the
guidewire antegradely into the duodenum via the PTGBD
route and then the guidewire was used retrogradely
(Figure 3). In 1 patient, EGS was done via peroral
cholangioscopy (POCS) with a GIF-XP260 (Olympus)
because the cystic duct branched caudally from the
common bile duct and this was considered to be a very
difficult case for EGS. The procedure was started by
inserting the GIF-XP260 into the common bile ductFigure 2 Outcome of 46 elderly patients with acute
cholecystitis received EGS. EGS, endoscopic gallbladder stenting;
PTGBD, percutaneous transhepatic gallbladder drainage; PTGBA,
percutaneous transhepatic gallbladder aspirationafter endoscopic sphincterotomy. We endoscopically
explored the cystic duct and then easily inserted the
guidewire and the cannula into the duct. Then the
guidewire was advanced retrogradely through the can-
nula and coiled within the gallbladder. Afterwards, we
exchanged the GIF-XP260 for the GIF-Q260, and a
double pigtail stent was advanced into the gallbladder
over the wire (Additional file 3).
Permanent EGS was useful for prevention of cholecyst-
itis in 31 elderly patients who were poor surgical candi-
dates. Their clinical characteristics and outcomes are
listed in Table 2. The average age of the patients was 82.19
± 7.15 years (mean ± SD). Sequelae of cerebral infarction
were present in 14 patients, dementia in 13 patients, se-
vere heart disease in 1 patient, cerebral hemorrhage in 1
patient, malignant mesothelioma in 1 patient, and
polymyalgia rheumatica in 1 patient. The follow-up period
ranged from 1 month to 5 years. In 30 of 31patients
(96.7%), there was no recurrence of cholecystitis and 29
patients (93.5%) remained asymptomatic for 1 month to 5
years (until death or the end of the study period). Sixteen
patients (51.6%) died from 1 month to 5 years after the
procedure due to aspiration pneumonia, heart failure,
cerebral infarction, gastric cancer, or malignant mesotheli-
oma. Two patients developed late complications. Patient
no. 3 developed vomiting at 2 months and 8 months after
EGS. We diagnosed her as acute cholecystitis from the US
and CT findings (occlusion at 2 months and migration at
8 months). After the stent was exchanged with ERC, the
symptoms soon resolved. Following the second exchange,
there have been no further complications. Patient no. 5
underwent removal of the gallbladder stent at 3.5 years
after EGS because he developed a liver abscess (without
cholecystitis). He was treated with antibiotics and the ab-
scess resolved after 2 months. We did not reinsert a
Figure 3 A guidewire has been passed antegradely into the duodenum via the PTGBD route (A), and EGS was performed by using the
guidewire retrogradely (B).
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scheduled stent exchange was not done, the other 29
patients (93.5%) did not have any late complications.
Discussion
The definitive treatment for acute cholecystitis is chole-
cystectomy [1,2], but in critically ill elderly patients, the
mortality rate of emergency cholecystectomy can reach
30% [3,4]. Several authors have described the usefulness
of PTGBD or PTGBA for such poor surgical candidates
[5-8]. However, we sometimes encounter patients who
cannot tolerate the percutaneous transhepatic approach
(e.g., because of anticoagulant/antiplatelet therapy, dis-
seminated intravascular coagulation, gallbladder malpo-
sition, or severe contracture). Such patients are likely to
develop intra-abdominal bleeding, biloma or even biliary
peritonitis, if these procedures are performed. Recently,
ETGBD has been reported as an alternative to PTGBD
or PTGBA [9-12]. Although it is possible to wash the
gallbladder via an ETGBD tube, there is a danger of the
tube being pulled out by elderly patients and it cannot
be left in the gallbladder over the long-term.
Otherwise EGS could be a viable strategy for long-
term management of symptomatic cholelithiasis in pa-
tients who are poor surgical candidates. EGS has been
shown to be an effective long-term option in cirrhosis
patients with cholelithiasis as a bridge to liver trans-
plantation [13-17]. Studies on EGS have demonstrated a
favorable clinical outcome up to 3 years after stenting
without any need for routine replacement of the stent
[14,15]. In a prospective follow-up study, Lee et al. [18]
also showed that at least 80% of 20 patients undergoing
EGS maintain stent patency without requiring stent ex-
change for at least 2 years. In the present series, we
performed permanent EGS in 31 elderly patients. As aresult, 30 patients (96.7%) had no recurrence of chole-
cystitis and 29 patients (93.5%) remained asymptomatic
for the duration of their survival. There were no late
complications in 14 patients after follow up for more
than 3 years, 9 patients after follow up for more than 4
years, and 1 patient after follow up for more than 5
years. Accordingly, this study has demonstrated the lon-
gest good clinical outcome for up to 5 years after EGS in
comparison with earlier studies without routine stent re-
placement [10,12]. Stents are thought to protect against
recurrent cholecystitis by occupying the lumen of the
cystic duct, thereby preventing stone impaction [24]. It
has also been postulated that after probable occlusion of
the stent, adequate flow of bile from the gallbladder to
the duodenum still occurs along the outer surface of the
stent through capillary action, a phenomenon known as
“wicking” [24]. Moreover, the stent may prevent bile flow
from the common hepatic duct into the cystic duct. In
our series, we found that the gallbladders of 12 patients
became very small.
Only 2 patients developed late complications. One pa-
tient (Patient no. 3) had 2 episodes of recurrent chole-
cystitis at 2 months and 8 months after EGS (stent
occlusion at 2 months and stent migration at 8 months).
When occlusion occurred at 2 months, we thought that
the probable cause was placing the stent without wash-
ing sludge out of the gallbladder with saline. After that,
we had no recurrent cholecystitis due to occlusion of
stents because we washed the gallbladder several times
with 20 mL of sterile saline when EGS was performed.
Stent migration at 8 months was caused by strong intes-
tinal peristalsis, so we inserted the next stent as far as
the fundus of the gallbladder because the previous stent
had only reached the neck of the gallbladder. Subse-
quently, none of the stents have fallen out. We think
Table 2 Outcome of stenting




Outcome, time from initial stenting
1 65 M Cerebral infarction (sequelae) Gallstone No Died of aspiration pneumonia (1 month)
2 79 M Cerebral infarction (sequelae) Gallstone No Alive (60 months)
3 79 F Cerebral infarction (sequelae) Sludge Yes Stent occlusion (2 months) and stent migration
(8 months): alive after 2 exchanges (59 months)
4 88 F Cerebral infarction (sequelae) Gallstone No Died of aspiration pneumonia (56 months)
5 77 M Severe heart disease Gallstone Yes Liver abscess (44 months): alive after drainage
(57 months)
6 91 F Cerebral infarction (sequelae) Gallstone No Died of gastric cancer, 24 months
7 85 F Dementia Gallstone No Alive (56 months)
8 86 F Dementia Gallstone No Died of aspiration pneumonia (11 months)
9 93 M Dementia Gallstone No Died of aspiration pneumonia (51 months)
10 78 M Dementia Gallstone No Alive (52 months)
11 85 M Cerebral infarction (sequelae) Sludge No Died of heart failure (22 months)
12 76 F Cerebral infarction (sequelae) Sludge No Alive (52 months)
13 83 M Cerebral infarction (sequelae) Sludge No Died of heart failure (2 months)
14 93 M Dementia Gallstone No Died of heart failure (26 months)
15 88 F Cerebral infarction (sequelae) Gallstone No Died of heart failure (35 months)
16 84 M Dementia Gallstone No Died of aspiration pneumonia (2 months)
17 74 M Cerebral infarction (sequelae) Gallstone No Alive (48 months)
18 86 M Cerebral infarction (sequelae) Gallstone No Alive (46 months)
19 73 M Pleura Malignant Mesothelioma Gallstone No Died of malignant mesothelioma (7 months)
20 75 M Cerebral infarction (sequelae) Gallstone No Died of aspiration pneumonia (16 months)
21 76 M Cerebral hemorrhage (sequelae) Gallstone No Alive (44 months)
22 94 F Dementia Gallstone No Alive (41 months)
23 79 F Cerebral infarction (sequelae) Gallstone No Died of aspiration pneumonia (1 month)
24 93 F Dementia Gallstone No Died of heart failure (26 months)
25 71 M Dementia Gallstone No Alive (17 months)
26 82 F Polymyalgia rheumatica Gallstone No Died of aspiration pneumonia (5 months)
27 82 M Dementia Gallstone No Died of cerebral infarction (29 months)
28 85 F Dementia Gallstone No Alive (48 months)
29 86 M Dementia Gallstone No Alive (43 months)
30 76 F Dementia Gallstone No Alive (26 months)
31 86 F Cerebral infarction (sequelae) Gallstone No Alive (11 months)
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dus of the gallbladder and wash the gallbladder several
times with sterile saline when EGS is performed to pre-
vent stent migration and occlusion. In 1 patient (Patient
no. 5), the stent was removed at 3.5 years after EGS be-
cause of a liver abscess without cholecystitis. The major
cause of liver abscess may have been inadequate flow in
the common bile duct because EST was not performed
since that patient was on antiplatelet therapy. We rec-
ommend performing EST if possible and opening the
stent side holes if that is impossible to obtain adequate
flow in the common bile duct after EGS.In 1984, Kozarek [25] introduced endoscopic transpapillary
cannulation of the gallbladder. Subsequently, new cath-
eters and guidewires have been developed to facilitate
selective cannulation of the cystic duct and gallbladder
[10,12,20,25]. Several other authors have attempted
EGS and ETGBD in patients with acute cholecystitis
[9-25]. The most recent evidenced-based report on
ETGBD by Hirota et al. recommends it as an option for
gallbladder drainage [2]. Clinical success was achieved
in all 31 patients (100%) with acute cholecystitis by
performing EGS within 3 days. Moreover, after successful
emergency EGS, patients were discharged from hospital
Maekawa et al. BMC Gastroenterology 2013, 13:65 Page 6 of 7
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hospitalization compared with PTGBD or ETGBD.
We consider that EGS and ETGBD are best indicated
for patients with acute cholecystitis in whom transhepatic
route cannot be used. Ferritis et al. [9], Toyota et al. [10],
Kjaer et al. [11], and Itoi et al. [12] reported ETGBD suc-
cess rates of 89% (16/18), 82% (18/22), 70.6% (24/34), and
83.7% (38/43) in smaller series. Our success rate for emer-
gency EGS was 77.5% (31/40), which is similar to the suc-
cess rate for ETGBD. We believe that EGS is slightly more
difficult than ETGBD because the stent is harder to ma-
nipulate compared with an ETGBD tube (a 5Fr soft drain
tube is often used for ETGBD). We encountered 3 cases
in which we could not place a stent in the gallbladder des-
pite inserting the guidewire, because of cystic duct occlu-
sion by stones in 2 cases and severe kinking of the cystic
duct in 1 case. Moreover, emergency EGS for acute chole-
cystitis is more difficult than elective EGS because the cys-
tic duct often shows stricture or obstruction in acute
patients. In our series, the success rate of emergency EGS
was 77.5% (31/40) and this was lower than that of elective
EGS (100%, 6/6).
EGS has not become very popular so far. The main reason
is difficulty in negotiating the cystic duct and gallbladder
with the guide wire. We used microcatheters for 4 difficult
patients, and used POCS for 1 patient. The microcatheters
used in 4 cases were designed for abdominal angiography
and were adapted to the EGS procedure. After the
microcatheter and 0.018 inch guidewire were advanced
through the ERCP cannula, we could pass severe strictures
and kinks of the cystic duct in all 4 cases. Thus, a
microcatheter is useful for contrast studies of the cystic
duct and for crossing strictures and kinks, but more
highly visible and softer microcatheters should be de-
veloped. Barkay et al. [26] reported successful cannula-
tion of the cystic duct by visualization with the
SpyGlass cholangiopancreatography system (SpyGlass
Direct Visualization System; Microvasive Endoscopy,
Boston Scientific, Natick, MA) with EGS in a patient
with cystic duct obstruction and acute cholecystitis. In
1 of our patients, a novel EGS technique using POCS
was tried. POCS enabled us to endoscopically explore
the cystic duct and easily insert the guidewire into the
duct by using the angulation and rotation of the GIF-
XP260. In our opinion, use of a microcatheter and
POCS could increase the technical success rate of EGS.
Our study showed that EGS can be effective for eld-
erly patients with acute cholecystitis who are poor sur-
gical candidates. Generally, EGS is associated with a
higher risk of aspiration pneumonia in comparison
with PTGBA because EGS is performed by peroral en-
doscopy. EGS should be performed as rapidly as pos-
sible and improvement of EGS technology is needed in
the future.Conclusions
We conclude that EGS can be effective for elderly pa-
tients with acute cholecystitis who are poor surgical can-
didates and the stent can be left for many months to
several years. However, further investigations will be
needed to establish the appropriate role of EGS.
Additional files
Additional file 1: Standard EGS procedure. Cannulating the bile duct
and cystic duct with an over-the-wire ERCP cannula. The guide wire was
advanced retrogradely through the cannula into the gallbladder and a
7Fr double pig-tail stent was then advanced.
Additional file 2: Difficult EGS case using a microcatheter. We
accomplished EGS by using an 0.018 inch guide wire and microcatheter
to pass through a severe stricture of the cystic duct.
Additional file 3: EGS via peroral cholangioscopy using a GIF-XP260.
We inserted the GIF-XP260 into the common duct, explored the cystic duct,
and advanced the guide wire into the gallbladder. Then we exchanged
GIF-XP260 for GIF-Q260, and advanced a double pigtail stent.
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